Pharmaceutical News

RSS

Curie-Cancer, DNA Therapeutics renew partnership to identify new class of cancer drugs

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and DNA Therapeutics, a biopharmaceutical company that is developing a new class of cancer drugs, are renewing their partnership.

5 Mar 2014

$Meta-analysis study shows association between BTMs s-CTX, s-PINP and risk of future fractures$

Meta-analysis study shows association between BTMs s-CTX, s-PINP and risk of future fractures

A new study by an International Osteoporosis Foundation (IOF) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) scientific working group summarizes the clinical performance of serum procollagen type I N propeptide (s-PINP) and serum C-terminal cross-linking telopeptide of type I collagen (s-CTX) in fracture risk prediction in untreated individuals in prospective cohort studies.

5 Mar 2014

Stock-outs of ARV drugs in Central African Republic impact health of HIV-infected people

According to Pierre-Marie David of the University of Montreal's Faculty of Pharmacy, stock-outs of antiretroviral (ARV) drugs in recent years in the Central African Republic have had a dramatic impact on the health of HIV-infected people.

5 Mar 2014

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work, published online in the journal Nature, is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.

5 Mar 2014

Dr. Reddy's Laboratories launches Moxifloxacin Hydrochloride Tablets

Dr. Reddy's Laboratories Ltd. announced today that it has launched Moxifloxacin Hydrochloride Tablets, 400 mg, a therapeutic equivalent generic version of Avelox (moxifloxacin HCl) tablets 400 mg in the US market on March 04, 2014, following the approval by the United States Food & Drug Administration.

5 Mar 2014

Georgia Regents Medical Center explores new treatment for Parkinson's disease-related constipation

Georgia Regents Medical Center is among about a dozen centers nationally exploring the potential of a new drug that may offer relief to people with Parkinson's who have failed standard approaches to treating constipation.

5 Mar 2014

HPV vaccine offers protection against cervical abnormalities in young women

The HPV vaccine offers significant protection against cervical abnormalities in young women, suggests a paper published on bmj.com today.

5 Mar 2014

Alzheimer's drug pioneer to be awarded Israel Prize for Medicine

Israel's Minister of Education Shai Piron has announced that the Israel Prize for Medicine will be awarded to the Hebrew University of Jerusalem's Prof. Marta Weinstock-Rosin. A professor emeritus at the Hebrew University's School of Pharmacy-Institute for Drug Research in the Faculty of Medicine, Weinstock-Rosin is best known for developing Exelon, a blockbuster drug for the treatment of confusion and dementia related to Alzheimer's and Parkinson's diseases.

5 Mar 2014

Mcl-1 protein enables NSCLC to survive radiation and drug treatments

Researchers at the Translational Genomics Research Institute have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments.

5 Mar 2014

Women using DMPA injection more likely to acquire HIV than women using NET-EN

Women who used an injectable contraceptive called DMPA were more likely to acquire HIV than women using a similar product called NET-EN, according to a secondary analysis of data from a large HIV prevention trial called VOICE, researchers from the National Institutes of Health-funded Microbicide Trials Network reported today at the 21st Conference on Retroviruses and Opportunistic Infections in Boston.

5 Mar 2014

Study: Combination intervention completely eliminates HIV transmission

A computer model has created the most effective formula for reducing the spread of HIV among drug users in New York City over the next 25 years.

5 Mar 2014

Ambit to provide overview of quizartinib drug candidate at Barclays Global Healthcare Conference

Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the Company's participation at the Barclays Global Healthcare Conference to be held at the Loews Miami Hotel in Miami Beach, FL, March 10-13, 2014.

4 Mar 2014

New AskRx version 1.0 enables patients to ask health and medication questions

RxWiki, Inc. announced today the launch of AskRx version 1.0, enabling patients to ask Digital Pharmacists™ health and medication questions.

4 Mar 2014

Drug that unleashes immune system can produce lasting remissions in patients with melanoma

A drug that unleashes the immune system to attack cancer can produce lasting remissions and hold the disease in check - for more than two years, in some cases - in many patients with advanced melanoma, according to a new study by researchers at Dana-Farber Cancer Institute, Johns Hopkins University, Yale University, and allied institutions.

4 Mar 2014

Researchers identify drug using yeast model that reduces levels of toxic protein in brains of AD patients

Using a yeast model of Alzheimer's disease (AD), Whitehead Institute researchers have identified a drug that reduces levels of the toxic protein fragment amyloid-β (Aβ) and prevents at least some of the cellular damage caused when Aβ accumulates in the brains of AD patients.

4 Mar 2014

Protamine antidote can be effective in reversing low-molecular-weight heparin

Low-molecular-weight heparin is commonly used in surgeries to prevent dangerous blood clots. But when patients experience the other extreme - uncontrolled bleeding - in response to low-molecular-weight heparin, there is no antidote.

4 Mar 2014

New approach to breast reconstruction surgery decreases use of postoperative opioid painkiller

A new approach to breast reconstruction surgery aimed at helping patients' bodies get back to normal more quickly cut their postoperative opioid painkiller use in half and meant a day less in the hospital on average, a Mayo Clinic study found.

4 Mar 2014

Drug that blocks LTA4 hydrolase enzyme plays key role in body's inflammatory response

There have been great expectations regarding the production of a drug to block the enzyme LTA4 hydrolase, which plays a key role in the body's inflammatory response.

4 Mar 2014

New findings point the way toward potentially more effective HIV vaccine

In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2.

4 Mar 2014

Naurex's GLYX-13 receives FDA Fast Track designation

Naurex Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.

4 Mar 2014

Pharmaceutical News

Curie-Cancer, DNA Therapeutics renew partnership to identify new class of cancer drugs

Meta-analysis study shows association between BTMs s-CTX, s-PINP and risk of future fractures

Stock-outs of ARV drugs in Central African Republic impact health of HIV-infected people

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

Dr. Reddy's Laboratories launches Moxifloxacin Hydrochloride Tablets

Georgia Regents Medical Center explores new treatment for Parkinson's disease-related constipation

HPV vaccine offers protection against cervical abnormalities in young women

Alzheimer's drug pioneer to be awarded Israel Prize for Medicine

Mcl-1 protein enables NSCLC to survive radiation and drug treatments

Women using DMPA injection more likely to acquire HIV than women using NET-EN

Study: Combination intervention completely eliminates HIV transmission

Ambit to provide overview of quizartinib drug candidate at Barclays Global Healthcare Conference

New AskRx version 1.0 enables patients to ask health and medication questions

Drug that unleashes immune system can produce lasting remissions in patients with melanoma

Researchers identify drug using yeast model that reduces levels of toxic protein in brains of AD patients

Protamine antidote can be effective in reversing low-molecular-weight heparin

New approach to breast reconstruction surgery decreases use of postoperative opioid painkiller

Drug that blocks LTA4 hydrolase enzyme plays key role in body's inflammatory response

New findings point the way toward potentially more effective HIV vaccine

Naurex's GLYX-13 receives FDA Fast Track designation

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News